According to Myovant Sciences
's latest financial reports the company has $0.27 B in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2022-03-31 | $0.43 B | -36.61% |
2021-03-31 | $0.68 B | 760.02% |
2020-03-31 | $79.64 M | -48.97% |
2019-03-31 | $0.15 B | 43.68% |
2018-03-31 | $0.10 B | -39.93% |
2017-03-31 | $0.18 B | |
2016-03-31 | $N/A |
Company | Cash on Hand | differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | $0.20 B | -24.14% | ๐บ๐ธ USA |